针对犬无浆体属和埃立克体属抗体的硅表面多重免疫测定（Accuplex）是犬蜱传病原体筛查的可靠选择。 机翻

中文关键词（术语机标，非人工翻译）：传染病 · 实验室检查 · 寄生虫防控

摘要

To evaluate the diagnostic performance of a point-of-care (POC) test (SNAP 4Dx Plus; Idexx Laboratories Inc) versus a proprietary silicon surface multiplex immunoassay (SSMIA) test (Accuplex; Antech Diagnostics Inc) with indirect fluorescent antibody as the reference method (REFERENCE) for detecting antibodies against Anaplasma spp and Ehrlichia spp in dogs and to compare SSMIA test results with period prevalences reported by the Companion Animal Parasite Council (CAPC).

Anonymized retention-released serum samples from dogs in the US submitted to a commercial laboratory between July 1, 2023, and September 30, 2024, were classified as true positive or true negative for each antibody via REFERENCE. Performance metrics (sensitivity, specificity, and Cohen κ) were calculated (REFERENCE as the standard) for SSMIA versus POC. Additional separate serum samples from dogs in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania underwent SSMIA testing alone in July 2024, and results were compared with respective period prevalence data reported by the CAPC.

Test methods did not differ significantly for detection of antibodies against Anaplasma spp (n = 310 samples). Silicon surface multiplex immunoassay was significantly more sensitive than POC for Ehrlichia spp antibody detection (n = 309 samples). Another 2,031 samples underwent SSMIA testing alone, and positivity rates were generally higher for SSMIA detection as compared to CAPC reporting.

These findings support SSMIA as a robust option for routine tick-borne pathogen exposure screening in dogs.

Our work provides veterinarians with field and comparative performance data on 2 commercially available tests, informing evidence-based contextualized diagnostic options.

摘要为 PubMed/NLM 公开许可元数据；全文版权归出版方所有，本平台不存储、不转载。